2.Patterns of brain injury in neonatal hypoxic-ischemic encephalopathy on magnetic resonance imaging: recommendations on classification.
Chinese Journal of Contemporary Pediatrics 2017;19(12):1225-1233
Although there are unified criteria for the clinical diagnosis and grading of neonatal hypoxic-ischemic encephalopathy (HIE), clinical features and neuropathological patterns vary considerably among the neonates with HIE due to birth asphyxia in the same classification. The patterns and progression of brain injury in HIE, which is closely associated with long-term neurodevelopment outcomes, can be well shown on magnetic resonance imaging (MRI), but different sequences may lead to different MRI findings at the same time. It is suggested that diffusion-weighted imaging sequence be selected at 2-4 days after birth, and the conventional MRI sequence at 4-8 days. The major patterns of brain injury in HIE on MRI are as follows: injury of the thalamus and basal ganglia and posterior limbs of the internal capsules; watershed injury involving the cortical and subcortical white matter; focal or multifocal minimal white matter injury; extensive whole brain injury. Severe acute birth asphyxia often leads to deep grey matter injury (thalamus and basal ganglia), and the brain stem may also be involved; the pyramidal tract is the most susceptible white matter fiber tract; repetitive or intermittent hypoxic-ischemic insults, with inflammation or hypoglycemia, usually cause injuries in the watershed area and deep white matter. It is worth noting that sometimes the pattern of brain injury among those described above cannot be determined exactly, but rather a predominant one is identified; not all cases of HIE have characteristic MRI findings.
Brain
;
diagnostic imaging
;
Brain Injuries
;
classification
;
diagnostic imaging
;
Diffusion Magnetic Resonance Imaging
;
methods
;
Humans
;
Hypoxia-Ischemia, Brain
;
diagnostic imaging
;
Infant, Newborn
;
Magnetic Resonance Imaging
;
methods
4.Guidelines for neonatal skin management in the neonatal intensive care unit (2021).
Group EVIDENCE-BASED MEDICINE ; Society NEONATOLOGIST ; Association CHINESE MEDICAL DOCTOR
Chinese Journal of Contemporary Pediatrics 2021;23(7):659-670
Neonates are easily suffering from local or systematic infections due to their vulnerable skin barrier function, which leads to the increasing risk of death. Therefore, it is important to protect neonatal skin integrity and prevent neonatal skin injury in the neonatal intensive care unit (NICU). Based on Grading of Recommendations Assessment, Development and Evaluation (GRADE) and current evidence, the guidelines for neonatal skin management in the NICU were developed to provide recommendations on routine skin care and prevention and treatment of iatrogenic skin injury of neonates for health care providers.
Humans
;
Infant, Newborn
;
Intensive Care Units, Neonatal
;
Skin
5.Chinese Expert Consensus on Clinical Application of Single-pill Combination of Cholesterol-lowering Agents
Chinese College of Cardiovascular Physician,Chinese Medical Doctor Association ; Junbo GE
Chinese Circulation Journal 2024;39(5):433-443
Effective lipid management can significantly reduce the burden of atherosclerotic cardiovascular disease(ASCVD).However,lipid management for ASCVD prevention and treatment in China still faces the challenges of low attainment rate and poor adherence.An increasing body of evidence suggests that a single-pill combination(SPC)of statin and non-statin agents is effective for improving blood lipid control rate,improving treatment adherence,and reducing adverse cardiovascular events.To standardize the clinical application of the cholesterol-lowering single-pill combination therapy in China,the"Chinese Expert Consensus on Clinical Application of Single-pill Combination of Cholesterol-lowering Agents"was developed with the efforts of a number of domestic experts from cardiovascular,cerebrovascular,endocrinological,and pharmacological fields.The advantages in clinical application and clinical research of cholesterol-lowering SPC were elaborated in this consensus,and the clinical pathway of lipid management for ASCVD prevention and treatment was formulated.Meanwhile,suggestions on the applicable population,usage and dosage,and management of adverse events of cholesterol-lowering SPC were provided.
6.Expert consensus on integrated traditional Chinese and Western medicine diagnosis and treatment of chronic hepatitis B
Expert Committee on Hepatology,Doctor Society of Integrative Medicine,Chinese Medical Doctor Association ; Xianbo WANG
Journal of Clinical Hepatology 2024;40(5):884-892
Chronic hepatitis B(CHB)is still a major public health issue in China,and without effective control,it can further progress to liver cirrhosis and liver cancer,bringing huge social and economic burdens.At present,antiviral therapy is the main treatment method for CHB,and integrated traditional Chinese and Western medicine therapy is the characteristic treatment method for CHB in China and can improve clinical efficacy by complementing each other's advantages.In order to promote the concept integrated traditional Chinese and Western medicine collaborative diagnosis and treatment,facilitate the development of integrated traditional Chinese and Western medicine diagnosis and treatment techniques for CHB,and establish standardized disease diagnosis and treatment regimens,Expert Committee on Hepatology in Doctor Society of Integrative Medicine,Chinese Medical Doctor Association,established a consensus expert group to discuss and formulate Expert consensus on integrated traditional Chinese and Western medicine diagnosis and treatment of chronic hepatitis B,which elaborated on the concept of integrated traditional Chinese and Western medicine collaborative diagnosis and treatment from the four aspects of CHB epidemiology,pathogenesis and etiology,integrated traditional Chinese and Western medicine diagnosis and syndrome differentiation,and integrated traditional Chinese and Western medicine therapy and proposed related recommendations,in order to improve the prognosis and quality of life of CHB patients.
7.Experts consensus on integrated traditional Chinese and Western medicine diagnosis and treatment of primary biliary cholangitis
Expert Committee on Hepatology,Doctor Society of Integrative Medicine,Chinese Medical Doctor Association ; Xianbo WANG
Journal of Clinical Hepatology 2024;40(9):1757-1766
Primary biliary cholangitis(PBC)is a chronic autoimmune liver disease.In recent years,related studies in China and globally have provided some evidence-based medical evidence for the integrated traditional Chinese and Western medicine treatment of PBC.Based on the latest diagnosis and treatment experience and guidelines in China and globally,Expert Committee on Hepatology,Doctor Society of Integrative Medicine,Chinese Medical Doctor Association,organized related experts in China to formulate this consensus,in order to provide guidance and reference for clinicians in the diagnosis,TCM syndrome differentiation,and integrated traditional Chinese and Western medicine treatment of PBC.
8.Expert consensus on enteral nutrition management of preterm infants(2024)
Nutritional Committee of Neonatology Branch of Chinese Medical Doctor Association ; Preterm Committee of Neonatology Branch of Chinese Medical Doctor Association ; Editorial Committee of Chinese Journal of Contemporary Pediatrics ; Xiao-Mei TONG ; Chao CHEN
Chinese Journal of Contemporary Pediatrics 2024;26(6):541-552
Providing adequate and balanced nutrition for preterm infants,especially extremely/very preterm infants,is the material basis for promoting their normal growth and development and improving long-term prognosis.Enteral nutrition is the best way to feed preterm infants.Previous systematic reviews have shown that using evidence-based standardized feeding management strategies can effectively promote the establishment of full enteral feeding,reduce the duration of parenteral nutrition,improve the nutritional outcomes of preterm infants,and not increase the risk of necrotizing enterocolitis or death.Based on relevant research in China and overseas,the consensus working group has developed 20 recommendations in 5 aspects including the goal of enteral nutrition,transitioning to enteral nutrition,stable growth period enteral nutrition,supplementation of special nutrients,and monitoring of enteral nutrition for preterm infants,using the Grading of Recommendations Assessment,Development and Evaluation.The aim is to provide recommendations for healthcare professionals involved in the management of enteral nutrition for preterm infants,in order to improve the clinical outcomes of preterm infants.
9.Expert consensus on enteral nutrition management for preterm infants in special situations(2024)
Nutritional Committee of Neonatology Branch of Chinese Medical Doctor Association ; Preterm Committee of Neonatology Branch of Chinese Medical Doctor Association ; Editorial Committee of Chinese Journal of Contemporary Pediatrics ; Chao CHEN ; Xiao-Mei TONG
Chinese Journal of Contemporary Pediatrics 2024;26(7):665-676
Establishing enteral nutrition after the birth of preterm infants presents numerous challenges,particularly for those in special situations.Various disease factors and medical interventions impede the establishment of enteral feeding,leading to conflicts and controversies regarding feeding goals,feeding methods,and the challenges and solutions faced by these infants.A critical issue for clinical physicians is how to safely and promptly establish enteral nutrition to achieve full enteral feeding as quickly as possible.The consensus formulation working group,based on both domestic and overseas research,adopted the Grading of Recommendations Assessment,Development and Evaluation,and formed an expert consensus on enteral nutrition management for preterm infants in special situations.This consensus provides 14 recommendations for 9 common special situations,aiming to offer guidance on enteral nutrition management for preterm infants to improve their short and long-term outcomes.
10.Consensus on the application of clinical whole genome sequencing in the diagnosis of genetic diseases.
Society of Medical Geneticists, Chinese Medical Doctor Association ; Subspecialty Group of Endocrindogic, Hereditary and Metabolic Diseases, the Society of Pedratrics, Chinese Medical Association ; Clinical Genetics Group, Adolescent Medicine Committee, Chinese Medical Doctor Association ; Molecular Diagnosis Society, Shanghai Medical Association
Chinese Journal of Pediatrics 2019;57(6):419-423